Particulates in allergen extracts - PowerPoint PPT Presentation

1 / 13
About This Presentation
Title:

Particulates in allergen extracts

Description:

How Did Precipitate Issue Arise? ... Aqueous extracts precipitate more than their glycerinated counterparts. Aqueous SRW commonly precipitates ... – PowerPoint PPT presentation

Number of Views:100
Avg rating:3.0/5.0
Slides: 14
Provided by: cber55
Category:

less

Transcript and Presenter's Notes

Title: Particulates in allergen extracts


1
Particulates in allergen extracts
2
Historical Perspective
  • Precipitates recognized for many years
  • Early efforts (1970s) by industry to
    characterize precipitates
  • Physical descriptions
  • Solubility properties
  • Early efforts by industry to remove precipitates
  • Manufacturing changes (e.g., bulk settling
    steps)
  • Formulation changes (e.g., extraction fluids)

3
(No Transcript)
4
(No Transcript)
5
How Did Precipitate Issue Arise?
  • Appearance of precipitates noted during Team
    Biologics inspections of several firms
    (99-present)
  • Areas in which precipitates were observed by
    inspectors
  • bulk containers
  • final containers
  • retain samples
  • customer complaint and product return files

6
Precipitated SRW Extract
7
Precipitated SRW Extract
8
Current Knowledge
  • Aqueous extracts precipitate more than their
    glycerinated counterparts
  • Aqueous SRW commonly precipitates
  • Precipitates are a primary cause of physician
    complaints (visual appearance) and product
    returns to industry
  • Precipitates do not appear to be caused by
    microbial contamination
  • Extraction ratio/concentration of extract and
    phenol may contribute to precipitation

9
(No Transcript)
10
Current Regulatory Position
  • No shipment of final containers exhibiting
    precipitates
  • Development of in-house quality control programs
    (identify and describe precipitates)
  • Validation of any reprocessing procedures
    performed on precipitated extracts
  • Modification of labeling to address precipitates
  • Submit Biological Product Deviation Reports on
    precipitated lots to CBER
  • If no approved license supplement in place for
    reprocessing or reworking of precipitated
    products, one should be submitted

11
Dosage and Administration section 21 CFR 201.57
(j)
  • Parenteral drug products should be inspected
    visually for particulate matter and discoloration
    whenever solution and container permit.

12
Recommended additions to Description,
Warnings, and Dosage and Administration
  • A statement indicating that precipitation occurs.
  • A description of the typical appearance of the
    precipitant.
  • A statement that precipitated extracts should not
    be used.

13
Summary
  • Precipitates occur in allergenic extracts
  • Aqueous extracts precipitate more than
    glycerinated extracts
  • Almost all precipitated extracts are
    unstandardized
  • Knowledge gaps on precipitated extracts exist
  • Collaborating with industry to fill knowledge
    gaps
  • Prudent regulatory approach
Write a Comment
User Comments (0)
About PowerShow.com